Boston Scientific remains in recovery mode following a cyberattack, SecurityWeek reports, with the medical device manufacturer still working to restore normal operations after the incident.

The company, a major supplier of cardiology and surgical devices, has not yet declared the incident closed. That detail alone should interest any CIO running a production-heavy enterprise: recovery timelines for industrial and medical manufacturers routinely stretch past the initial disclosure, and the remediation phase often costs more than the intrusion itself.

What does this change for security leaders?

The practical question is what a still-ongoing recovery at a device maker signals to other enterprises. It signals that incident closure is a process, not an announcement. Firms that build physical products face tighter constraints than pure software businesses: they must validate restored systems against regulatory and quality requirements before lines run at full speed.

For CIOs, the takeaway is straightforward. Build your incident-response budget around the recovery tail, not the breach headline. Restoration, validation and lost production typically dominate the final invoice.

SecurityWeek's report did not specify the attack vector, the threat actor, or a financial damage estimate at the time of publication. We will update this story as Boston Scientific discloses further detail.